Library
2-TFMXP
2-TFMXP is the 2-trifluoromethyl analogue of methoxphenidine (MXP). Very little formal pharmacology is published; all dosing is extrapolated from user reports and structural activity relationships. Compared with MXP it appears 1.5-2× more potent and noticeably more stimulating with increased mania potential. Marked inter-individual variability exists; some users report minimal effects below 30 mg while others reach full dissociation at 25 mg. Start low and titrate carefully.
Also known as: 2-tfm-mxp, TFMXP, 2‑trifluoromethyl‑MXP, 2‑TFM‑diphenidine
Classification
- Chemical: Diarylethylamine
- Psychoactive: Dissociative
- Tag: Research-Chemical
Effects
- Stimulation
- Somatic Lightness
- Pain Relief
- Incoordination
- Impaired Balance
- Numbness
- Depersonalization
- Derealization
- Motor Control Loss
- Euphoria
- Time Distortion
- Conceptual Thinking
- Perception Of Bodily Lightness
- Tactile Suppression
- Spatial Disorientation
- Visual Disconnection
- Increased Music Appreciation
- Internal Hallucination
Routes of Administration
Oral
Dosage
- Threshold: 5-10 mg
- Light: 10-25 mg
- Common: 25-45 mg
- Strong: 45-70 mg
- Heavy: 70 mg+ (NOT RECOMMENDED)
Duration
- Onset: 0.33-1 h
- Comeup: 0.5-1 h
- Peak: 1.5-4 h
- Offset: 2-4 h
- After Effects: 8-24 h
- Total Duration: 6-10 h
Sublingual
Dosage
- Threshold: 4-8 mg
- Light: 8-20 mg
- Common: 20-40 mg
- Strong: 40-60 mg
- Heavy: 60 mg+ (NOT RECOMMENDED)
Duration
- Onset: 0.17-0.67 h
- Comeup: 0.33-0.75 h
- Peak: 1.25-3.5 h
- Offset: 3.5-8 h
- After Effects: 8-24 h
- Total Duration: 6-10 h
Insufflated
Dosage
- Threshold: 3-5 mg
- Light: 5-15 mg
- Common: 15-30 mg
- Strong: 30-45 mg
- Heavy: 45 mg+ (NOT RECOMMENDED)
Duration
- Onset: 0.08-0.25 h
- Comeup: 0.25-0.5 h
- Peak: 1.5-4 h
- Offset: 3-6.5 h
- After Effects: 6.5-24 h
- Total Duration: 5-9 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
